Infinity Pharmaceuticals Management Performance

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.7  0.25  8.47%

Analysis of Infinity Pharmaceuticals manpower and management performance can provide insight into Infinity Pharmaceuticals stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Infinity Pharmaceuticals future performance. Please also check Risk vs Return Analysis.

Infinity Pharmaceuticals Management Effectiveness

The company has return on total asset (ROA) of (26.58) % which means that it has lost $26.58 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (78.61) % meaning that it created substantial loss on money invested by shareholders.

Infinity Pharmaceuticals Insider Trading

Infinity Pharmaceuticals Stakeholders

Adelene Perkins Chairman of The Board, CEO and Pres, MBA
Joseph Pearlberg Vice President - Clinical Development, Ph.D
Melissa Hackel Vice President - Finance, MBA
William Bertrand Executive Vice President General Counsel
Lawrence Bloch CFO, Executive Vice President Chief Business Officer, MBA
Julian Adams President of RandD
Winston Lam Executive Vice President General Counsel, MBA
Sujay Kango Executive Vice President Chief Commercial Officer, MBA
Vito Palombella Chief Scientific Officer and Executive VP
Jeffrey Berkowitz Independent Director
Norman Selby Lead Outside Independent Director, MBA
Jose Baselga Independent Director, Ph.D
Michael Venuti Independent Director, Ph.D
Michael Kauffman Independent Director
Jaren Madden Sr. Director of Investor Relations and Corporate Communications
Eric Lander Independent Director, Ph.D
Anthony Evnin Independent Director, Ph.D
Gwendolyn Fyfe Independent Director
Ian Smith Independent Director
Franklin Moss Chief Strategist and Advisor
David Roth Chief Medical Officer

Leadership

Infinity Pharmaceuticals Top Executives
Adelene Perkins  Chairman
Chairman of The Board, CEO and Pres
Joseph Pearlberg  President
Vice President - Clinical Development

Tenure Analysis

Infinity Pharmaceuticals Employment Tenure
Infinity Pharmaceuticals employes about 48 people. The company is managed by 21 executives with total tenure of roughly 69 years, averanging almost 3.0 years of service per executive having 2.0 employee per reported executive.

Earnings

Infinity Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.56February 28, 2017
Infinity Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Manpower Efficiency

Return on Infinity Pharmaceuticals Manpower
Revenue Per Employee 703.9 K
Net Loss Per Employee 351.4 K
Net Loss Per Executive 3.3 M
Working Capital Per Employee 3.8 M
Working Capital Per Executive 8.8 M

Per Employee

Infinity Pharmaceuticals Per Employee Growth Over Time

Net Income Per Employee

Revenue Per Employee

Number of Employees

Infinity Pharmaceuticals Number of Employees Analysis
Infinity Pharmaceuticals Inc is rated fifth overall in number of employees category among related companies. The total workforce of Pharmaceutical Products industry is currently estimated at about 414. Infinity Pharmaceuticals retains roughly 48.0 in number of employees claiming about 12% of equities listed under Pharmaceutical Products industry.